Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but rather strengthened, researchers said. “Overall, we did not find any indication of a weaker immune
HQ Team March 2, 2024: The US Centers for Disease Control and Prevention Control has revised its Covid-19 isolation recommendations by suggesting patients return to normal activities if they are free of fever for at least 24 hours.
HQ Team February 28, 2024: An international team of researchers conducted a large study on the safety of COVID-19 vaccines and found potential adverse effects associated with vaccination. While affirming the overall safety and efficacy of vaccination, the
HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave of the Covid-19 pandemic, according to a study. The drug was prescribed off-label in 2020
HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency. The Centers for Disease
By K. Leelamoni The coronavirus variant JN. 1 has been causing concern among health experts and the public alike. JN.1 is surging in many countries, including the US, China, India and Singapore. Its prevalence has been rapidly increasing
HQ Team December 13, 2023: Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of the Covid-19 virus to contribute to their persistence and recurrence of the infection, a study
HQ Team October 16, 2023: Germany’s BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty vaccine may impact 2023 revenue of up to $900 million. This “represents BioNTech’s half under
HQ Team October 4, 2023: The US Food and Drug Administration has cleared Novavax’s updated Covid-19 vaccine for emergency use in adolescents 12 years of age or above, the regulator announced. The Emergency Use Authorisation permits individuals, who
HQ Team October 2, 2023: Hungarian-born biochemist Katalin Kariko and US immunologist Drew Weissman jointly won the Nobel Prize in Physiology or Medicine for their discoveries that led to the development of vaccines to fight the Covid-19 virus.